|1|MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor. (23135210)
Halon A.... Surowiak P.
|2|Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review. (23721765)
Brockbank E.C.... Barton D.P.
|3|Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer. (23906656)
Burger R.A.... Bookman M.A.
|4|Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity. (23868002)
Otsuka I.... Hoshi K.
|5|Increased incidence of severe gastrointestinal events with first-line paclitaxel, carboplatin, and vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. (23385285)
Mendivil A.A.... Goldstein B.H.
|6|OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. (22529265)
Aghajanian C.... Nycum L.R.
|7|Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. (22524817)
Suprasert P.... Manopunya M.
|8|Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. (21992853)
Coleman R.L.... Sood A.K.
|9|Para-aortic lymphadenectomy for primary fallopian tube cancer. (20887989)
Koo Y.J.... Mok J.E.
|10|Junctional epithelial zones of the fallopian tube: cancer hotspots? (21131841)
Rabban J.T.... Zaloudek C.J.
|11|Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy. (22567506)
Healy N.A.... Sweeney K.J.
|12|Primary fallopian tube cancer in term pregnancy: a case report. (21614918)
Le A.... Wang Z.
|13|Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. (21815133)
McGonigle K.F.... Malpass T.W.
|14|Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (19901115)
Makhija S.... Matulonis U.
|15|Immunohistochemical findings in primary fallopian tube cancer. Case report. (20349798)
Raba G.... Kanczuga-Koda L.
|16|Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (19224848)
Teneriello M.G.... Asmar L.
|17|High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. (19574767)
Hirst J.E.... Field M.
|18|Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (19091388)
Kehoe S.M.... Chi D.S.
|19|Case report: Occurrence of fallopian tube cancer in a patient with previous history of estrogen receptor positive breast cancer. (20103847)
Chung C.... Yen Y.
|20|A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. (18554700)
Konner J.... Aghajanian C.A.
|21|Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. (18423560)
Nimeiri H.S.... .
|22|Fallopian tube cancer associated with paraneoplastic dermatomyositis -- asymptomatic multivisceral exacerbated dermatomyositis mimicking recurrent widespread malignant disease: case report. (18459555)
Seeber J.... Zeimet A.G.
|23|Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group. (18597837)
Morgan M.A.... Egorin M.J.
|24|Fallopian tube cancer: radical surgery, extended field radiation and chemotherapy in 24 personal cases treated with "intent to cure". (18973932)
|25|Second primary malignancies in females with primary fallopian tube cancer. (17266029)
Riska A.... Brennan P.
|26|A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. (17343605)
Micha J.P.... Brown J.V.
|27|Fallopian tube cancer: stepchild or mother? (18053873)
|28|The incidence of primary fallopian tube cancer in the United States. (17961642)
Stewart S.L.... Michaud F.
|29|A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. (16445606)
Benoit M.F.... Hannigan E.V.
|30|The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: a case report. (16515624)
Damayanti Z.... Sng J.H.
|31|The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer. (15991534)
Gojnic M.... Jeremic K.
|32|A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. (15581974)
Berkenblit A.... Cannistra S.A.
|33|Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. (15331919)
Markman M.... Lindner D.
|34|Primary fallopian tube cancer--a ten year review. Clinicopathological study of 12 cases. (15285322)
Liapis A.... Creatsas G.
|35|Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. (14675679)
Markman M.... Belinson J.
|36|Preoperative diagnosis of fallopian tube cancer by imaging. (14628888)
Mikami M.... Fukuiya T.
|37|Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. (12354934)
Jongsma A.P.... Kenemans P.
|38|Fallopian tube cancer in a BRCA1 mutation carrier: rapid development and failure of screening. (11810084)
HAcbert-Blouin M.N.... Foulkes W.D.
|39|Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. (11205221)
Scholz H.S.... Petru E.
|40|Fallopian tube cancer as a feature of BRCA1-associated syndromes. (10926816)
Sobol H.... Eisinger F.
|41|Treatment of fallopian tube cancer. Review of the literature. (10985612)
Takeshima N.... Hasumi K.
|42|Practice guidelines: fallopian tube cancer. Society of Gynecologic Oncologists Clinical Practice Guidelines. (9507528) |1998|
|43|Primary fallopian tube cancer: a review of the literature. (9643524)
|44|Fallopian tube cancer: incidence and role of lymphatic spread. (8751549)
di Re E.... Baiocchi G.
|45|DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer. (11578443)
HellstrAPm A.C.... Auer G.
|46|Fallopian tube cancer metastatic to the breast. (8005136)
Fishman A.... Kaplan A.L.
|47|Staging rules for gestational trophoblastic tumors and fallopian tube cancer. (1317647)
|48|Fallopian tube cancer. The Roswell Park experience. (2249208)
Rose P.G.... Tsukada Y.
|49|Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. (2297745)
Lehtovirta P.... SeppAolAo M.
Kimmel K.D.... Christman J.E.